Show simple item record

dc.contributor.authorBousquet, J; Devillier, P; Anto, JM; Bewick, M; Haahtela, T; Arnavielhe, S; Bedbrook, A; Murray, R; van Eerd, M; Fonseca, JA; Almeida, MM; Bom, AT; Menditto, E; Passalacqua, G; Stellato, C; Triggiani, M; Ventura, MT; Vezzani, G; Annesi-Maesano, I; Bourret, R; Bosse, I; Caimmi, D; Cartier, C; Demoly, P; Just, J; Portejoie, F; Siroux, V; Viart, F; Bergmann, KC; Keil, T; Klimek, L; Mosges, R; Pfaar, O; Shamai, S; Zuberbier, T; Mullol, J; Valero, A; Spranger, O; Tomazic, PV; Kowalski, ML; Kuna, P; Kupczyk, M; Raciborski, F; Samolinski, B; Toppila-Salmi, SK; Valovirta, E; Cruz, AA; Sarquis-Serpa, F; da Silva, J; Stelmach, R; Larenas-Linnemann, D; Gonzalez, MR; Cabanas, MTB; Kvedariene, V; Valiulis, A; Chavannes, NH; Fokkens, WJ; Ryan, D; Sheikh, A; Bachert, C; Hellings, PW; VandenPlas, O; Ballardini, N; Kull, I; Melen, E; Westman, M; Wickman, M; Bindslev-Jensen, C; Eller, E; Bosnic-Anticevich, S; O'Hehir, RE; Agache, I; Bieber, T; Casale, T; Gemicioglu, B; Ivancevich, JC; De Vries, G; Sorensen, M; Yorgancioglu, A; Laune, D
dc.date.accessioned2020-07-01T08:22:20Z
dc.date.available2020-07-01T08:22:20Z
dc.date.issuedAUG
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/20.500.12481/4801
dc.description.abstractBackgroundMultimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary. MethodsWe undertook a 1-year prospective observational study in which 4 210 users and 32585days were monitored in 19 countries. Five visual analogue scales (VAS) assessed the daily burden of the disease (i.e., global evaluation, nose, eyes, asthma and work). Visual analogue scale levels <20/100 were categorized as Low burden and VAS levels 50/100 as High burden. ResultsVisual analogue scales global measured levels assessing the global control of the allergic disease were significantly associated with allergic multimorbidity. Eight hypothesis-driven patterns were defined based on Low and High VAS levels. There were <0.2% days of Rhinitis Low and Asthma High or Conjunctivitis High patterns. There were 5.9% days with a Rhinitis HighAsthma Low pattern. There were 1.7% days with a Rhinitis HighAsthma HighConjunctivitis Lowpattern. A novel Rhinitis HighAsthma HighConjunctivitis High pattern was identified in 2.9% days and had the greatest impact on uncontrolled VAS global measured and impaired work productivity. Work productivity was significantly correlated with VAS global measured levels. ConclusionsIn a novel approach examining daily symptoms with mobile technology, we found considerable intra-individual variability of allergic multimorbidity including a previously unrecognized extreme pattern of uncontrolled multimorbidity.
dc.titleDaily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
dc.title.alternativeALLERGY
dc.identifier.DOI-ID10.1111/all.13448
dc.identifier.volume73
dc.identifier.issue8
dc.identifier.startpage1622
dc.identifier.endpage1631
dc.identifier.issn/e-issn0105-4538
dc.identifier.issn/e-issn1398-9995


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record